marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q1
hinzugefügt 07.05.2024
Fusion Pharmaceuticals Bilanz 2011-2024 | FUSN
Bilanz Jährlich Fusion Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-22.5 M | -8.18 M | -46.2 M | -90.5 M | -65.3 M | -28.8 M | - | - | - | - | - | - | - |
Langfristige Schulden |
34.8 M | 34.2 M | 5.51 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
4.16 M | 1.44 M | 1.22 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 4.31 M | 98.6 M | 47.7 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
16.2 M | 15.1 M | 12.5 M | 11.9 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
63.4 M | 56.8 M | 20.8 M | 16.2 M | 103 M | 49.3 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
333 K | 333 K | 1.54 M | 1 M | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-377 M | -282 M | -194 M | -113 M | -34.8 M | -18.6 M | - | - | - | - | - | - | - |
Vermögenswerte |
286 M | 219 M | 252 M | 311 M | 69.4 M | 31.4 M | - | - | - | - | - | - | - |
Zahlungsmittel |
61.5 M | 43.9 M | 52.9 M | 90.5 M | 67.1 M | - | - | - | - | - | - | - | - |
Buchwert |
222 M | 162 M | 231 M | 295 M | -33.5 M | -17.9 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
222 M | 162 M | 231 M | 295 M | -33.5 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Fusion Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
49.7 M | 34.8 M | 34.6 M | 34.5 M | 34.8 M | 34.2 M | 34.1 M | 9.63 M | 5.56 M | 5.51 M | 5.78 M | 6.08 M | 6.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
82 M | 63.4 M | 64.9 M | 65.3 M | 65.7 M | 56.8 M | 55.4 M | 29.2 M | 20.5 M | 20.8 M | 21.8 M | 18.6 M | 18.2 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 10.3 M | 10.3 M | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
333 K | 333 K | 333 K | 333 K | 333 K | 333 K | 412 K | 707 K | 1.1 M | 1.54 M | 2.29 M | 1.73 M | 1 M | 1 M | 1 M | 1 M | 1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-410 M | -377 M | -349 M | -331 M | -306 M | -282 M | -257 M | -233 M | -214 M | -194 M | -177 M | -158 M | -131 M | -113 M | -113 M | -113 M | -113 M | -34.8 M | -34.8 M | -34.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
324 M | 286 M | 253 M | 268 M | 267 M | 219 M | 238 M | 228 M | 236 M | 252 M | 268 M | 282 M | 297 M | 311 M | 311 M | 311 M | 311 M | 69.4 M | 69.4 M | 69.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
27.8 M | 61.5 M | 26.8 M | 32 M | 54.9 M | 43.9 M | 107 M | 63 M | 60.7 M | 52.9 M | 40.3 M | 29.5 M | 41.1 M | 92.4 M | 90.5 M | 90.5 M | 90.5 M | 65.3 M | 65.3 M | 65.3 M | - | 29.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
242 M | 222 M | 188 M | 203 M | 201 M | 162 M | 183 M | 199 M | 215 M | 231 M | 246 M | 264 M | 279 M | 295 M | 295 M | 295 M | 295 M | 59.1 M | 59.1 M | 59.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
242 M | 222 M | 188 M | 203 M | 201 M | 162 M | 183 M | 199 M | 215 M | 231 M | 246 M | 264 M | 279 M | 295 M | 295 M | 295 M | 295 M | -33.5 M | -33.5 M | -33.5 M | -21.7 M | -17.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung